Active B12 Test Market Research Report Information By Type (Elisa Assay, Enzyme Immunoassay, and Others), By Application (Folate Deficiency Anemia, Pernicious Anemia, Macrocytic Anemia, and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

1 Report Prologue
2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain

5.3 Investment Feasibility Analysis

5.4 Price Factor Analysis

6 Global Active B12 Test Market, by Diagnosis

6.1 Introduction

6.2 ELISA assay

6.3 Enzyme immunoassay

6.4 Others

6.4.1 RIA Testing

7 Global Active B12 Test Market, by Indication

7.1 Introduction

7.2 Folate Deficiency Anemia

7.3 Pernicious Anemia

7.4 Macrocytic Anemia

7.5 Others

7.5.1 Diabetes Mellitus Type 1

7.5.2 Rheumatoid Arthritis

7.5.3 Systemic Lupus Erythematosus

8 Global Active B12 Test Market, by End User

8.1 Introduction

8.2 Hospitals

8.3 Medical laboratories

8.4 Clinical research organization

8.5 Others

8 Global Active B12 Test Market by Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 US

8.2.1.2 Canada

8.2.2 Latin America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 UK

8.3.1.4 Italy

8.3.1.5 Spain

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Republic of Korea

8.4.5 Australia

8.4.6 Rest of Asia-Pacific

8.5 Middle East & Africa

8.5.1 United Arab Emirates

8.5.2 Saudi Arabia

8.5.3 Oman

8.5.4 Kuwait

8.5.5 Qatar

8.5.6 Rest of Middle East & Africa

9 Company Landscape

9.1 Introduction

9.2 Market share Analysis

9.3 Key Development & Strategies

9.3.1 Key Developments

10 Company Profiles

10.1 Axis-Shield Diagnostics Ltd.

10.1.1 Company Overview

10.1.2 Product Overview

10.1.3 Financials

10.1.4 SWOT Analysis

10.2 Abbott

10.2.1 Company Overview

10.2.2 Product Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 Siemens Healthcare Private Limited

10.3.1 Company Overview

10.3.2 Product Overview

10.3.3 Financial Overview

10.3.4 Key Development

10.3.5 SWOT Analysis

10.4 F. Hoffmann-La Roche Ltd

10.4.1 Company Overview

10.4.2 Product/Business Segment Overview

10.4.3 Financial Overview

10.4.4 Key Development

10.4.5 SWOT Analysis

10.5 DiaSorin S.p.A.

10.5.1 Company Overview

10.5.2 Product Overview

10.5.3 Financial overview

10.5.4 Key Developments

10.6 LifeSpan BioSciences, Inc.

10.6.1 Company Overview

10.6.2 Product Overview

10.6.3 Financial Overview

10.6.4 Key Developments

10.7 Demeditec Diagnostics GmbH

10.7.1 Overview

10.7.2 Product Overview

10.7.3 Financials

10.7.4 Key Developments

10.7.5 SWOT Analysis

11 MRFR Conclusion

11.1 Key Findings

11.1.1 From CEO’s View Point

11.1.2 Unmet Needs of the Market

11.2 Key Companies to Watch

11.3 Prediction of Healthcare Industry

12 Appendix

LIST OF TABLES

Table 1 Global Active B12 Test Market Industry Synopsis, 2020-2027

Table 2 Global Active B12 Test Market Estimates & Forecast, 2020-2027, (USD Million)

Table 3 Global Active B12 Test Market, by Region, 2020-2027, (USD Million)

Table 4 Global Active B12 Test Market, by Product Type, 2020-2027, (USD Million)

Table 5 Global Active B12 Test Market, by Systems, 2020-2027, (USD Million)

Table 6 Global Active B12 Test Market, by End User, 2020-2027, (USD Million

Table 7 North America Active B12 Test Market, by Product Type, 2020-2027, (USD Million)

Table 8 North America Active B12 Test Market, by Systems, 2020-2027, (USD Million)

Table 9 North America Active B12 Test Market, by End User, 2020-2027, (USD Million)

Table 10 U.S. Active B12 Test Market, by Product Type, 2020-2027, (USD Million)

Table 11 U.S. Active B12 Test Market, by Systems, 2020-2027, (USD Million)

Table 12 U.S. Active B12 Test Market, by End User, 2020-2027, (USD Million)

Table 13 Canada Active B12 Test Market, by Product Type, 2020-2027, (USD Million)

Table 14 Canada Active B12 Test Market, by Systems, 2020-2027, (USD Million)

Table 15 Canada Active B12 Test Market, by End User, 2020-2027, (USD Million)

Table 16 South America Active B12 Test Market, by Product Type, 2020-2027, (USD Million)

Table 17 South America Active B12 Test Market, by Systems, 2020-2027, (USD Million)

Table 18 South America Active B12 Test Market, by End User, 2020-2027, (USD Million)

Table 19 Europe Active B12 Test Market, Product Type, 2020-2027, (USD Million)

Table 20 Europe Active B12 Test Market, by Systems, 2020-2027, (USD Million)

Table 21 Europe Active B12 Test Market, by End User, 2020-2027, (USD Million)

Table 22 Western Europe Active B12 Test Market, by Product Type, 2020-2027, (USD Million)

Table 23 Western Europe Active B12 Test Market, by Systems, 2020-2027, (USD Million)

Table 24 Western Europe Active B12 Test Market, by End User, 2020-2027, (USD Million)

Table 25 Eastern Europe Active B12 Test Market, by Product Type, 2020-2027, (USD Million)

Table26 Eastern Europe Active B12 Test Market, by Systems, 2020-2027, (USD Million)

Table 27 Eastern Europe Active B12 Test Market, by End User, 2020-2027, (USD Million)

Table 28 Asia Pacific Active B12 Test Market, by Product Type, 2020-2027, (USD Million)

Table 29 Asia Pacific Active B12 Test Market, by Systems, 2020-2027, (USD Million)

Table 30 Asia Pacific Active B12 Test Market, by End User, 2020-2027, (USD Million)

Table 31 Middle East & Africa Active B12 Test Market, by Product Type, 2020-2027, (USD Million)

Table 32 Middle East & Africa Active B12 Test Market, by Systems, 2020-2027, (USD Million)

Table 33 Middle East & Africa Active B12 Test Market, by End User, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Active B12 Test Market

Figure 3 Market Dynamics for Active B12 Test Market

Figure 4 Global Active B12 Test Market Share, by Product Type 2020

Figure 5 Global Active B12 Test Market Share, by Systems 2020

Figure 6 Global Active B12 Test Market Share, by End-User, 2020

Figure 7 Global Active B12 Test Market Share, by Region, 2020

Figure 8 North America Active B12 Test Market Share, by Country, 2020

Figure 9 Europe Active B12 Test Market Share, by Country, 2020

Figure 10 Asia Pacific Active B12 Test Market Share, by Country, 2020

Figure 11 Middle East & Africa Active B12 Test Market Share, by Country, 2020

Figure 12 Global Active B12 Test Market: Company Share Analysis, 2020 (%)

Figure 13 AXIS-SHIELD DIAGNOSTICS LTD.: KEY FINANCIALS

FIGURE 14 AXIS-SHIELD DIAGNOSTICS LTD.: SEGMENTAL REVENUE

FIGURE 15 AXIS-SHIELD DIAGNOSTICS LTD.: Geographical Revenue

Figure 16 Abbott: Key Financials

Figure 17 Abbott: Segmental Revenue

Figure 18 Abbott: Geographical Revenue

Figure 19 Siemens Healthcare Private Limited: Key Financials

Figure 20 Siemens Healthcare Private Limited: Segmental Revenue

Figure 21 Siemens Healthcare Private Limited: Geographical Revenue

Figure 22 F. Hoffmann-La Roche Ltd: Key Financials

Figure 23 F. Hoffmann-La Roche Ltd: Segmental Revenue

Figure 24 F. Hoffmann-La Roche Ltd: Geographical Revenue

Figure 25 DiaSorin S.p.A.: Key Financials

Figure 26 DiaSorin S.p.A.: Segmental Revenue

Figure 27 DiaSorin S.p.A.: Geographical Revenue

Figure 28 LifeSpan BioSciences, Inc.: Key Financials

Figure 29 LifeSpan BioSciences, Inc.: Segmental Revenue

Figure 30 LifeSpan BioSciences, Inc.: Geographical Revenue

Figure 31 DEMEDITEC DIAGNOSTICS GMBH: Key Financials

Figure 32 DEMEDITEC DIAGNOSTICS GMBH: Segmental Revenue

Figure 33 DEMEDITEC DIAGNOSTICS GMBH: Geographical Revenue